Vanguard Group »

Vyne Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $874k 444k 1.97
2024-03-31 $214k 70k 3.07
2023-12-31 $116k 50k 2.33
2023-09-30 $181k 45k 4.04
2023-06-30 $184k 45k 4.10
2023-03-31 $117k 38k 3.08